ZNF681 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.932800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.687970E-01
Normal-vs-Stage2
1.935960E-01
Normal-vs-Stage3
1.318960E-01
Normal-vs-Stage4
1.692170E-01
Stage1-vs-Stage2
1.821590E-01
Stage1-vs-Stage3
1.279810E-01
Stage1-vs-Stage4
8.082600E-01
Stage2-vs-Stage3
1.627000E-01
Stage2-vs-Stage4
4.964800E-01
Stage3-vs-Stage4
1.571210E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.923150E-01
Normal-vs-AfricanAmerican
1.152750E-01
Normal-vs-Asian
2.510300E-02
Caucasian-vs-AfricanAmerican
3.391000E-01
Caucasian-vs-Asian
8.657400E-01
AfricanAmerican-vs-Asian
4.929800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.822550E-01
Normal-vs-Female
1.240420E-03
Male-vs-Female
1.371990E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.196600E-01
Normal-vs-Age(41-60Yrs)
2.039000E-01
Normal-vs-Age(61-80Yrs)
1.885560E-01
Normal-vs-Age(81-100Yrs)
1.295840E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.952800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.392200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
3.784200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.649400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
6.603400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
9.705000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.136600E-03
Normal-vs-Daily Drinker
1.665990E-01
Normal-vs-Weekly Drinker
1.646840E-01
Normal-vs-Occasional Drinker
1.942980E-01
Normal-vs-Social Drinker
7.038800E-03
Non Drinker-vs-Daily Drinker
3.520400E-01
Non Drinker-vs-Weekly Drinker
2.766200E-01
Non Drinker-vs-Occasional Drinker
9.596200E-01
Non Drinker-vs-Social Drinker
8.415000E-01
Daily Drinker-vs-Weekly Drinker
9.927800E-01
Daily Drinker-vs-Occasional Drinker
3.965200E-01
Daily Drinker-vs-Social Drinker
5.506800E-01
Weekly Drinker-vs-Occasional Drinker
3.552400E-01
Weekly Drinker-vs-Social Drinker
5.181200E-01
Occasional Drinker-vs-Social Drinker
8.787200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.726200E-01
Normal-vs-Grade 2
2.903600E-01
Normal-vs-Grade 3
3.081600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.616600E-01
Grade 1-vs-Grade 3
8.514000E-01
Grade 1-vs-Grade 4
4.726200E-01
Grade 2-vs-Grade 3
3.877200E-01
Grade 2-vs-Grade 4
2.903600E-01
Grade 3-vs-Grade 4
3.081600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.958560E-01
Normal-vs-NonDiabetic
1.786390E-01
Diabetic-vs-NonDiabetic
4.193800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.600100E-03
Normal-vs-NoPancreatitis
1.873970E-01
Pancreatitis-vs-NoPancreatitis
1.847420E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.084180E-03
Normal-vs-N1
1.955360E-01
N0-vs-N1
4.665000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.891000E-01
Normal-vs-TP53-NonMutant
2.981200E-01
TP53-Mutant-vs-TP53-NonMutant
8.215400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
